What Is Diabetic Kidney Disease?
Diabetic kidney disease — also called diabetic nephropathy — is a form of chronic kidney disease (CKD) caused by damage to the kidneys' filtering units (the glomeruli) from years of chronic high blood sugar and high blood pressure. The kidneys gradually lose their ability to filter waste from the blood, and over time that loss becomes irreversible.
The disease progresses through five stages, measured by GFR (glomerular filtration rate). Early stages are often silent. Later stages bring fatigue, swelling in the legs and around the eyes, nausea, loss of appetite, and cognitive difficulty often described as "uremic brain fog." By Stage 5 — end-stage renal disease (ESRD) — the kidneys can no longer sustain life on their own, and dialysis or a transplant is required.
Diabetes is the single leading cause of kidney failure in the United States, accounting for nearly half of all new cases of ESRD each year.
How Kidney Disease Qualifies for Disability
Chronic kidney disease is evaluated under Section 6.00 (Genitourinary Disorders) of the Blue Book. There are two listings most diabetic CKD claims are decided under:
Chronic Kidney Disease (without dialysis)
Reduced glomerular filtration rate, demonstrated by a creatinine clearance of 20 ml/min or less (or an eGFR of 20 ml/min/1.73m² or less), measured on at least two occasions at least 90 days apart during a consecutive 12-month period.
Chronic Kidney Disease with Dialysis
Ongoing chronic hemodialysis or peritoneal dialysis as described under 6.00E — treatment that is ongoing or that is expected to last 12 months or longer.
If your kidney disease is at an earlier stage and doesn't yet meet either listing, the RFC pathway still applies — documenting fatigue, dietary restrictions, cognitive impacts (often called "renal brain fog"), and the sheer volume of medical appointments (in-center dialysis runs three times a week, which alone makes reliable work attendance close to impossible).
Evidence SSA Needs to See
Kidney claims are won on lab numbers. The SSA wants to see trended data — not a single snapshot — alongside specialist notes and treatment records:
| Evidence Type | What It Shows | How to Get It |
|---|---|---|
| GFR / eGFR Lab Results | Measures kidney filtration rate — the key metric for Listing 6.02. You need 2+ results, 90+ days apart. | Nephrologist or PCP lab orders. |
| Serum Creatinine / BUN | Indicates buildup of waste products from declining kidney function. | Standard blood panel. |
| Urinalysis / Urine Albumin | Shows protein leakage indicating kidney damage. The albumin-to-creatinine ratio tracks progression over time. | Lab orders from nephrologist. |
| Dialysis Records | Documents treatment schedule, complications, and access issues (fistula, catheter problems). | Dialysis center records. |
| Kidney Biopsy Results | Confirms diabetic nephropathy versus other causes of kidney damage. | Nephrologist — not always performed. |
| Treatment Records | Shows progression through medications (ACE inhibitors, ARBs) and dietary interventions despite which kidney function continues to decline. | Nephrologist records. |
RFC Impact: How Kidney Disease Limits Work
Even where the listings aren't met, kidney disease imposes a heavy functional burden. These are the limitations the SSA evaluates on RFC:
| Limitation | How Kidney Disease Causes It |
|---|---|
| Fatigue / energy | Uremia and anemia from declining kidney function cause persistent exhaustion that does not improve with rest. |
| Cognitive function ("brain fog") | Uremic toxin accumulation impairs concentration, memory, and decision-making. |
| Dietary restrictions | Strict potassium, phosphorus, and fluid limits affect job flexibility — no shared meals, no easy travel. |
| Frequent medical appointments | Hemodialysis = 4 hours, 3x/week. Add transit, recovery, lab visits, and nephrology follow-up. |
| Fluid management | Edema, shortness of breath, and cramping between dialysis sessions. |
| Medication side effects | Phosphate binders, blood pressure agents, EPO injections — a collective side-effect load that compounds fatigue. |
What Your Doctor Needs to Document
- Specific diagnosis — "Stage 4 CKD, diabetic nephropathy, eGFR 24 ml/min, declining 4 ml/min/year."
- Two GFR readings 90+ days apart — required for Listing 6.02.
- Dialysis schedule if applicable — modality (HD vs PD), frequency, duration, access type.
- Functional limitations — explicit statements about fatigue, brain fog, ability to maintain a schedule.
- Progression over time — annual GFR comparison demonstrating decline despite treatment.
Pro tip
If you're being followed by a nephrologist for declining function but haven't started dialysis, make sure your GFR is being checked at least every 3 months and the readings are being documented in the chart. You need a track record SSA can read.
Common Mistakes
Not tracking GFR over 12 months
Listing 6.02 requires two readings 90+ days apart within a consecutive 12-month period. Sporadic labs won't meet the criterion.
Missing the dialysis documentation window
A new dialysis patient needs documentation that treatment is expected to last 12+ months. A nephrologist letter should make this explicit.
Failing to document how fatigue affects daily work capacity
Uremic fatigue is real and disabling, but it's invisible without explicit physician documentation.